Forest Lab's Ceftazidime/avibactam Combination Receives Qualified Infectious Disease Product Designation from FDA
September 12, 2013 at 20:29 PM EDT
Forest Laboratories, Inc. (NYSE: FRX ), an international pharmaceutical manufacturer and marketer, today announced that the U.S. Food and Drug Administration (FDA) has designated its investigational drug, ceftazidime/avibactam,